Abstract:Background: Bone marrow-derived mesenchymal stem cells (MSCs) are of great therapeutic potential after myocardial ischemic injury. However, little is known about the biological characteristics of MSCs in patients with coronary artery disease and their effects on infracted myocardium. The present study evaluated the biological characteristics of MSCs from patients with coronary artery disease and their effects after being transplanted into infarcted myocardium using a rat model.Methods: Sternal bone marrow aspirates were taken at the time of coronary artery bypass graft surgery. Mononuclear cells isolated from bone marrow were cultured based on plastic adherence. The morphology and growth characteristics of MSCs were observed in primary and successive passages. A myocardial infarction model was created in 27 adult rats. Two weeks later, animals were randomized into two groups: culture medium (group I, n = 13) or MSCs (2 x 10(6)) from early passages labeled with BrdU (group II, n = 14) were injected into the infarcted myocardium. Echocardiography, histological examination, and reverse transcription-polymerase chain reaction (RT-PCR) were performed four weeks after cell transplantation.Results: Flow cytometry analyses demonstrated that adherent spindle cells from bone marrow are mesenchymal stem cells (positive for CD29 and CD44, but negative for CD34 and CD45). Growth curves showed that MSCs have great proliferative capability especially at early passages. MSCs implantation in the infarcted border zone improved left ventricular function significantly in group II compared with group I. However, despite improved left ventricular function, we did not observe significant regeneration of cardiac myocytes. Immunohistochemistry revealed only the expression of desmin in the engrafted MSCs, a marker of premature myocyte. Moreover, the improved left ventricular function in this study seemed to be secondary to the beneficial reverse remodeling induced by the increase of collagen in infarcted zone, the decrease in the adjacent myocardium, and the increase of neovascularization (capillary density: 192 +/- 7.8/ mm(2) in group II vs. 165 5.9/mm(2) in group I, P < 0.05). Reverse transcription-polymerase chain reaction (RT-PCR) results showed the expression levels of collagen 1, collagen III, SDF-1 (stromal cell-derived factor-1), and VEGF (vascular endothelia growth factor) in the infarcted border zone were significantly higher in the MSCs treated group.Conclusions: The MSCs from patients with coronary artery disease have a typical phenotype with highly proliferative potential and the engrafted MSCs may regulate extracellular collagens and cytokines to prevent the ventricular scar from pathologic thinning and attenuate the contractile dysfunction of the infarcted heart. (c) 2006 Elsevier Ireland Ltd. All rights reserved.

Mesenchymal stem cells with overexpression of Angiotensin-converting enzyme-2 improved the microenvironment and cardiac function in a rat model of myocardial infarction

SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction.

Pretreatment of Mesenchymal Stem Cells with Angiotensin II Enhances Paracrine Effects, Angiogenesis, Gap Junction Formation and Therapeutic Efficacy for Myocardial Infarction

Bone Marrow Mesenchymal Stem Cells Induce Angiogenesis and Attenuate the Remodeling of Diabetic Cardiomyopathy

Effects of Mesenchymal Stem Cells Transplantation on Post-Infarction Ventricular Remodeling in Rats

C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.

Mesenchymal Stem Cells with Enos Over-Expression Enhance Cardiac Repair in Rats with Myocardial Infarction

ACE2 Overexpression Improves Left Ventricular Remodeling and Function in Rats with Myocardial Infarction

Mesenchymal stem cells with overexpression of midkine enhance cell survival and attenuate cardiac dysfunction in a rat model of myocardial infarction

MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction

Ace2 Overexpression Ameliorates Left Ventricular Remodeling And Dysfunction In A Rat Model Of Myocardial Infarction

Mesenchymal Stem Cells Overexpressing Angiotensin-Converting Enzyme 2 Rescue Lipopolysaccharide-Induced Lung Injury

MSCs Modified with ACE2 Restore Endothelial Function Following LPS Challenge by Inhibiting the Activation of RAS

Effects of bone marrow mesenchymal stem cells in a rat model of myocardial infarction

Transplantation of Mesenchymal Stem Cells from Human Bone Marrow Improves Damaged Heart Function in Rats.

Overexpression of Csx/Nkx2.5 and GATA-4 Enhances the Efficacy of Mesenchymal Stem Cell Transplantation after Myocardial Infarction

Intravenous Transplantation of Mesenchymal Stem Cells Improves Cardiac Performance after Acute Myocardial Ischemia in Female Rats

Overexpression of MicroRNA-1 Improves the Efficacy of Mesenchymal Stem Cell Transplantation after Myocardial Infarction.

Mesenchymal Stem Cells Enhanced Cardiac Nerve Sprouting Via Nerve Growth Factor in a Rat Model of Myocardial Infarction

Effects of Combined Mesenchymal Stem Cells and Heme Oxygenase-1 Therapy on Cardiac Performance.

Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction.